TB Booster is a recombinant human type 5 adenovirus-based
tuberculosis vaccine, a globally innovative TB booster vaccine
for BCG-vaccinated population. Currently, BCG is the only available
TB vaccine in world and all newborns in the PRC are required to
receive the BCG vaccination. However, the efficacy of BCG declines
after 10 to 20 years from primary vaccination and no effective BCG booster vaccine is available. Our TB Booster candidate would be indicated for the 4 to 18 year-old age group in China, which had a total population of 290.0 million in 2017. The phase I clinical trials of our TB Booster candidate are expected to be completed in Canada by the end of 2019.
Copyright © ( 2017) CanSino Biologics Inc
For the record: 津ICP备14006666号-2